Skip to main content

Table 3 Comparison of controller medication adherence at 6 month follow-up by randomization group and by baseline elevated depressive symptoms, for students included in the analysis sample*

From: Exploring the impact of elevated depressive symptoms on the ability of a tailored asthma intervention to improve medication adherence among urban adolescents with asthma

 

Treatment

Control

Adjusted** odds ratio (95% CI)

p value

Meet criteria for elevated depressive symptoms at baseline:

      

Core behavior at 6 months**

      

Controller medication, adherent ≥ 5 of last 7 days

58.3

(7)

12.5

(2)

9.50 (1.35, 67.0)

0.024

Controller medication, not adherent < 5 of last 7 days

41.7

(5)

87.5

(14)

  

Do not meet criteria for elevated depressive symptoms at baseline:

      

Core behavior at 6 months*

      

Controller medication, adherent ≥ 5 of last 7 days

32.6

(15)

30.6

(15)

1.40 (0.53, 3.67)

0.49

Controller medication, not adherent < 5 of last 7 days

67.4

(31)

69.4

(34)

  
  1. *Students enrolled in Puff City and reporting a controller medication at baseline assessment. ** Adjusted for controller medication adherence at start of intervention.